PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12166462

Genetic engineering on a selective basis.

J Melone
View original source ↗Export metadata ↓

Abstract

The possibility of a disease-free world seems to be at the fingertips of the Human Genome Project, but not yet fully within its grasp. Consequently, the advent of the Human Genome Project has ushered in the necessity for a clear delineation of the definition of "disease." This very concept of disease initially must be defined before genetic treatment can be addressed, ensuring that only true disease, not every anomaly of the human condition, are made eligible for genetic alterations. The benefits of such a precautionary measure are innumerable, since a regulation standard could be established and evolutionary implications could be taken into consideration.

Explore related subjects

DiseaseEthical AnalysisGenetic EngineeringGenetic TherapyGerm CellsHealthHuman Genome ProjectHumansAnalytical ApproachBiomedical and Behavioral ResearchGenetics and ReproductionJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Melone. 2001. Genetic engineering on a selective basis.. https://pubmed.ncbi.nlm.nih.gov/12166462/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Structural location of disease-associated single-nucleotide polymorphisms.

Non-synonymous single-nucleotide polymorphism (nsSNP) of genes introduces amino acid changes to proteins, and plays an important role in providing genetic functional diversity. To understand the structural characteristics of disease-associated SNPs, we have mapped a set of nsSNPs derived from the online mendelian inheritance in man (OMIM) database to the structural surfaces of encoded proteins. These nsSNPs are disease-associated or have distinctive phenotypes. As a control dataset, we mapped a set of nsSNPs derived from SNP database dbSNP to the structural surfaces of those encoded proteins. Using the alpha shape method from computational geometry, we examine the geometric locations of the structural sites of these nsSNPs. We classify each nsSNP site into one of three categories of geometric locations: those in a pocket or a void (type P); those on a convex region or a shallow depressed region (type S); and those that are buried completely in the interior (type I). We find that the majority (88%) of disease-associated nsSNPs are located in voids or pockets, and they are infrequently observed in the interior of proteins (3.2% in the data set). We find that nsSNPs mapped from dbSNP are less likely to be located in pockets or voids (68%). We further introduce a novel application of hidden Markov models (HMM) for analyzing sequence homology of SNPs on various geometric sites. For SNPs on surface pocket or void, we find that there is no strong tendency for them to occur on conserved residues. For SNPs buried in the interior, we find that disease-associated mutations are more likely to be conserved. The approach of classifying nsSNPs with alpha shape and HMM developed in this study can be integrated with additional methods to improve the accuracy of predictions of whether a given nsSNP is likely to be disease-associated.

Disease↗
PubMed2003

Disease proteomics.

The sequencing of the human genome and that of numerous pathogens has opened the door for proteomics by providing a sequence-based framework for mining proteomes. As a result, there is intense interest in applying proteomics to foster a better understanding of disease processes, develop new biomarkers for diagnosis and early detection of disease, and accelerate drug development. This interest creates numerous opportunities as well as challenges to meet the needs for high sensitivity and high throughput required for disease-related investigations.

Disease↗